These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 30125008)

  • 1. Analysis of Patient-Provider Interactions Regarding the Burden and Treatment of Opioid-Induced Constipation in Adults with Chronic Noncancer Pain.
    Vallerand AH; Hendry S; Baldys E; Hu Y; Datto C
    Pain Med; 2019 May; 20(5):889-896. PubMed ID: 30125008
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Burden of Opioid-Induced Constipation: Discordance Between Patient and Health Care Provider Reports.
    LoCasale RJ; Datto C; Wilson H; Yeomans K; Coyne KS
    J Manag Care Spec Pharm; 2016 Mar; 22(3):236-45. PubMed ID: 27003553
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Patient and provider differences in the treatment of opioid-induced constipation: a qualitative study.
    Keller MS; Jusufagic A; Spiegel BMR
    BMC Gastroenterol; 2019 Nov; 19(1):182. PubMed ID: 31718543
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Opioid-Induced Constipation Survey in Patients with Chronic Noncancer Pain.
    Rauck RL; Hong KJ; North J
    Pain Pract; 2017 Mar; 17(3):329-335. PubMed ID: 26990277
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Patients' Self-Assessment of the Symptoms and Impact of Opioid-Induced Constipation: Results From a Prospective Observational Cohort Study of Japanese Patients With Cancer.
    Fumita S; Imai H; Harada T; Noriyuki T; Gamoh M; Akashi Y; Sato H; Kizawa Y; Tokoro A
    J Pain Symptom Manage; 2020 May; 59(5):1043-1051.e2. PubMed ID: 31805362
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Opioid-Induced Constipation Among Patients with Chronic Noncancer Pain in the United States, Canada, Germany, and the United Kingdom: Laxative Use, Response, and Symptom Burden Over Time.
    Coyne KS; Margolis MK; Yeomans K; King FR; Chavoshi S; Payne KA; LoCasale RJ
    Pain Med; 2015 Aug; 16(8):1551-65. PubMed ID: 25802051
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Evolving Role of Long-Term Pharmacotherapy for Opioid-Induced Constipation in Patients Being Treated for Noncancer Pain.
    Bowers BL; Crannage AJ
    J Pharm Pract; 2019 Oct; 32(5):558-567. PubMed ID: 29207909
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impact of constipation on opioid therapy management among long-term opioid users, based on a patient survey.
    Gupta S; Patel H; Scopel J; Mody RR
    J Opioid Manag; 2015; 11(4):325-38. PubMed ID: 26312960
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lubiprostone for Opioid-Induced Constipation Does Not Interfere with Opioid Analgesia in Patients with Chronic Noncancer Pain.
    Spierings EL; Brewer RP; Rauck RL; Losch-Beridon T; Mareya SM
    Pain Pract; 2017 Mar; 17(3):312-319. PubMed ID: 26990171
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Opioid-induced constipation negatively impacts pain management, productivity, and health-related quality of life: findings from the National Health and Wellness Survey.
    Bell T; Annunziata K; Leslie JB
    J Opioid Manag; 2009; 5(3):137-44. PubMed ID: 19662923
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Burden of Opioid-Induced Constipation in Younger Patients with Chronic Noncancer Pain.
    Gupta A; Coyne KS; Datto C; Venuti C
    Pain Med; 2018 Dec; 19(12):2459-2468. PubMed ID: 29420795
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Satisfaction with Therapy Among Patients with Chronic Noncancer Pain with Opioid-Induced Constipation.
    LoCasale RJ; Datto C; Margolis MK; Coyne KS
    J Manag Care Spec Pharm; 2016 Mar; 22(3):246-53. PubMed ID: 27003554
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Management of opioid-induced constipation.
    Prichard D; Norton C; Bharucha AE
    Br J Nurs; 2016 May 26-Jun 8; 25(10):S4-5, S8-11. PubMed ID: 27231750
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The impact of opioid-induced constipation among chronic pain patients with sufficient laxative use.
    LoCasale RJ; Datto CJ; Margolis MK; Tack J; Coyne KS
    Int J Clin Pract; 2015 Dec; 69(12):1448-56. PubMed ID: 26344578
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy of Lubiprostone for the Treatment of Opioid-Induced Constipation, Analyzed by Opioid Class.
    Webster LR; Brewer RP; Lichtlen P; Losch-Beridon T; Mareya S; Wang M
    Pain Med; 2018 Jun; 19(6):1195-1205. PubMed ID: 29897589
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Treatment with Naloxegol Versus Placebo: Pain Assessment in Patients with Noncancer Pain and Opioid-Induced Constipation.
    Webster L; Diva U; Tummala R; Sostek M
    Pain Pract; 2018 Apr; 18(4):505-514. PubMed ID: 28898536
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Treatment with prolonged-release oxycodone/naloxone improves pain relief and opioid-induced constipation compared with prolonged-release oxycodone in patients with chronic severe pain and laxative-refractory constipation.
    Poelaert J; Koopmans-Klein G; Dioh A; Louis F; Gorissen M; Logé D; Van Op den Bosch J; van Megen YJ
    Clin Ther; 2015 Apr; 37(4):784-92. PubMed ID: 25757607
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prevalence and Burden of Illness of Rome IV Chronic Idiopathic Constipation, Opioid-Induced Constipation, and Opioid-Exacerbated Constipation in the United States.
    Liang J; Almario CV; Chey WD; Higgins CS; Spiegel BMR
    Am J Gastroenterol; 2023 Nov; 118(11):2033-2040. PubMed ID: 37335135
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Discussions between patients with chronic pain and their primary care provider about opioids and pain relief during routine clinic encounters.
    Massey M; van den Berk Clark C; Fowler J; Scherrer JF
    J Opioid Manag; 2019; 15(2):137-146. PubMed ID: 31343715
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Opioid-induced Constipation: A Review of Health-related Quality of Life, Patient Burden, Practical Clinical Considerations, and the Impact of Peripherally Acting μ-Opioid Receptor Antagonists.
    Argoff CE
    Clin J Pain; 2020 Sep; 36(9):716-722. PubMed ID: 32554978
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.